Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

12/30/25 4:05:00 PM ET

Medical/Dental Instruments

Health Care

Get the next $MDLN alert in real time by email

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time.

The presentation will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline's Investor Relations website for 30 days following the event.

About Medline

Medline is the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries. For more information, visit www.medline.com.

Contacts

Investor Relations:

Karen King

Global Head of Investor Relations

Patrick Flaherty

Director, Investor Relations

(847) 247-7222

[email protected]

Media Relations:

Ben Fox

Vice President, Corporate Communications

(224) 327-9999

[email protected]

Source: Medline Inc.

Get the next $MDLN alert in real time by email

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

12/30/25 4:05:00 PM ET

$MDLN

Medical/Dental Instruments

Health Care

Get the next $MDLN alert in real time by email

Patrick Flaherty

Director, Investor Relations

(847) 247-7222

[email protected]

Media Relations:

Ben Fox

Vice President, Corporate Communications

(224) 327-9999

[email protected]

Source: Medline Inc.

Get the next $MDLN alert in real time by email

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$MDLN

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$MDLN

$MDLN
Insider Purchases

Large owner Gic Private Ltd sold $289,480,090 worth of shares (10,204,351 units at $28.37) and bought $364,999,974 worth of shares (12,586,206 units at $29.00) (SEC Form 4)

Director Mills Andrew J. was granted 30,655 units of Class B Common Stock and bought $74,999,974 worth of shares (2,586,206 units at $29.00) (SEC Form 4)

Director Mills Charles N. was granted 64,005 units of Class B Common Stock and bought $74,799,990 worth of shares (2,579,310 units at $29.00) (SEC Form 4)

$MDLN
Insider Trading

Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. converted options into 2,098,005 shares, sold $172,716,735 worth of shares (6,088,371 units at $28.37), disposed of 11,126,460 units of Class B Common Stock and disposed of 5,568,750 shares (SEC Form 4)

Director Healy Patrick J acquired 819,877 shares (SEC Form 4)

Large owner Gic Private Ltd sold $289,480,090 worth of shares (10,204,351 units at $28.37) and bought $364,999,974 worth of shares (12,586,206 units at $29.00) (SEC Form 4)

$MDLN
SEC Filings

SEC Form SCHEDULE 13G filed by Medline Inc.

Medline Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Leadership Update

SEC Form 424B4 filed by Medline Inc.

$MDLN
Press Releases